ECCRINE SQUAMOUS SYRINGOMETAPLASIA

ECCRINE SQUAMOUS SYRINGOMETAPLASIA was reported 36 times

ECCRINE SQUAMOUS SYRINGOMETAPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GRANULOCYTE COLONY STIMULATING FACTOR 1 0.0005
1 BUSULFAN 6 0.0004
2 VEMURAFENIB 4 0.0003
3 SIROLIMUS 3 0.0002
4 FLUDARABINE PHOSPHATE 7 0.0002
5 MITOXANTRONE HYDROCHLORIDE 1 0.0002
6 ANTI-THYMOCYTE GLOBULIN (RABBIT) 1 0.0001
7 TERAZOSIN HYDROCHLORIDE 1 0.0001
8 CLADRIBINE 1 0.0001
9 ENCORAFENIB 1 0.0001
10 SORAFENIB 2 0.0001
11 FELODIPINE 1 0.0001
12 REGORAFENIB 1 0.0001
13 AZACITIDINE 2 0.0001
14 CYTARABINE 4 0.0001
15 DABRAFENIB 1 0.0000
16 MYCOPHENILIC ACID 1 0.0000
17 DOCETAXEL 3 0.0000
18 DOCETAXEL ANHYDROUS 3 0.0000
19 PROGESTERONE 1 0.0000
20 MELPHALAN HYDROCHLORIDE 1 0.0000
21 PAZOPANIB HYDROCHLORIDE 1 0.0000
22 MYCOPHENOLIC ACID 1 0.0000
23 DOXORUBICIN HYDROCHLORIDE 1 0.0000
24 CYCLOSPORINE 3 0.0000
25 PEMETREXED DISODIUM 1 0.0000
26 SUNITINIB MALATE 1 0.0000
27 CISPLATIN 2 0.0000
28 TACROLIMUS OINTMENT 0.1% 3 0.0000
29 TACROLIMUS EXTENDED-RELEASE CAPSULES 3 0.0000
30 ESTRADIOL TRANSDERMAL 1 0.0000
31 ISOTRETINOIN 1 0.0000
32 TACROLIMUS 3 0.0000
33 ESTRADIOL 1 0.0000
34 DOXORUBICIN 1 0.0000
35 PREDNISOLONE ORAL SOLUTION 2 0.0000
36 PACLITAXEL 1 0.0000
37 CARBOPLATIN 1 0.0000
38 ADALIMUMAB 1 0.0000